Inhibition of WNK Kinases in NK Cells Disrupts Cellular Osmoregulation and Control of Tumor Metastasis

Ji Sung Kim1, John H Kehrl1

  • 1B-Cell Molecular Immunology Section, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Journal of Innate Immunity
|September 12, 2024
PubMed
Abstract

Insights

Pharmacologic inhibition of With-no-lysine (WNK) kinases impairs natural killer (NK) cell function, decreasing their volume, motility, and killing ability. This negatively impacts NK cell-mediated tumor metastasis control.

Area of Science:

  • Immunology
  • Cell Biology
  • Pharmacology

Background:

  • With-no-lysine (WNK) kinases regulate blood pressure, electrolyte balance, and cell osmoregulation.
  • WNK kinases are potential therapeutic targets for hypertension and stroke.
  • The role of WNK kinases in immune cells, particularly NK cells, is largely unknown.

Purpose of the Study:

  • To investigate the impact of WNK kinase inhibition on natural killer (NK) cell physiology.
  • To explore the mechanisms underlying WNK kinase inhibition effects on NK cells.
  • To assess the therapeutic implications of targeting WNK kinases in NK cell-mediated immunity.

Main Methods:

  • Utilized small-molecule WNK kinase inhibitors (WNK463 and WNK-IN-11).
  • Assessed effects on IL-2-activated NK cell volume, motility, and cytolytic activity.
  • Investigated downstream signaling pathways including AMPK, mTOR, Akt, and c-Myc phosphorylation.
  • Evaluated NK cell function in a tumor metastasis model in mice.

Main Results:

  • WNK kinase inhibition significantly reduced NK cell volume, motility, and cytolytic activity.
  • Inhibitors induced autophagy via AMPK activation and mTOR inhibition.
  • WNK inhibition altered Akt and c-Myc phosphorylation by disrupting kinase/phosphatase balance.
  • Pharmacologic inhibition of WNK kinases impaired NK cell-mediated control of tumor metastasis in vivo.

Conclusions:

  • Catalytic activity of WNK kinases is crucial for multiple NK cell functions.
  • Pharmacologic inhibition of WNK kinases detrimentally affects NK cell physiology and anti-tumor immunity.
  • Targeting WNK kinases may have unintended consequences for immune cell function.

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
859
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
154
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
1.6K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.7K